Email updates

Keep up to date with the latest news and content from BMC Microbiology and BioMed Central.

Open Access Highly Accessed Research article

Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent

Sarah Tubby, Michael Wilson and Sean P Nair*

Author Affiliations

Division of Microbial Diseases, UCL Eastman Dental Institute, 256 Gray's Inn Road, WC1X 8LD, UK

For all author emails, please log on.

BMC Microbiology 2009, 9:211  doi:10.1186/1471-2180-9-211

Published: 5 October 2009

Abstract

Background

One of the limitations of antibiotic therapy is that even after successful killing of the infecting microorganism, virulence factors may still be present and cause significant damage to the host. Light-activated antimicrobials show potential for the treatment of topical infections; therefore if these agents can also inactivate microbial virulence factors, this would represent an advantage over conventional antibiotic therapy. Staphylococcus aureus produces a wide range of virulence factors that contribute to its success as a pathogen by facilitating colonisation and destruction of host tissues.

Results

In this study, the ability of the light-activated antimicrobial agent methylene blue in combination with laser light of 665 nm to inactivate staphylococcal virulence factors was assessed. A number of proteinaceous virulence factors were exposed to laser light in the presence of methylene blue and their biological activities re-determined. The activities of V8 protease, α-haemolysin and sphingomyelinase were shown to be inhibited in a dose-dependent manner by exposure to laser light in the presence of methylene blue.

Conclusion

These results suggest that photodynamic therapy could reduce the harmful impact of preformed virulence factors on the host.